| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-19 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-18 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |